Drug of Abuse (DOA) Rapid Test - Amphetamine 1000ng/ml
MeriScreen by Meril
MERISCREEN Drug of Abuse Rapid Test for Amphetamine detection offers precise immunochromatographic screening at 1000ng/ml cutoff level using lateral flow immunoassay technology. This point-of-care diagnostic solution provides accurate urine-based amphetamine testing results within 5 minutes, available in both dip test and cassette formats. Essential for hospitals, rehabilitation centers, and occupational health facilities requiring reliable substance abuse screening. Meets clinical standards for drug testing protocols with consistent performance and easy-to-read results.
Product overview
MERISCREEN Drug of Abuse Rapid Test for Amphetamine detection offers precise immunochromatographic screening at 1000ng/ml cutoff level using lateral flow immunoassay technology. This point-of-care diagnostic solution provides accurate urine-based amphetamine testing results within 5 minutes, available in both dip test and cassette formats. Essential for hospitals, rehabilitation centers, and occupational health facilities requiring reliable substance abuse screening. Meets clinical standards for drug testing protocols with consistent performance and easy-to-read results.
Competitive lateral flow chromatographic immunoassay for qualitative detection of drugs in urine. Available in dip test and cassette formats. 20 drug targets with varying cutoff concentrations.
Technical specifications
| cutoff level | 1000 ng/ml |
| specimen type | Urine |
| test format | Dip test and Cassette |
| reading time | 5 minutes |
| test method | Lateral flow immunoassay |
Surgical Decision Engine
Cross-sell intelligence powered by product knowledge graph